Kairos Pharma, Ltd. share price logo

Kairos Pharma, Ltd.

AMEX: KAPA

$0.50

+0.03

(+5.49%)

Live

as on

Kairos Pharma, Ltd. Stock Performance

as on November 12, 2026 at 7:54 am IST

  • Day's Low

    Day's High

    $0.47
    $0.51
    downward going graph

    6.00%

    Downside

    2.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.42
    $7.28
    downward going graph

    16.36%

    Downside

    1356.00%

    Upside

    downward going graph

Kairos Pharma, Ltd. share price movements today

Previous Close
$0.47
Open
$0.47
Volume
243.6K
Market Cap
$1.7M
Day's Low - High
$0.47 - $0.51
52 Week Low - High
$0.42 - $7.28

Kairos Pharma, Ltd. Historical Returns

1 Month Return
-41.5 %
3 Month Return
-81.37 %
1 Year Return
-92.27 %
3 Year Return
0 %
5 Year Return
0 %

Kairos Pharma, Ltd. Stock Fundamentals & Key Indicators

Check Kairos Pharma, Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7M

EPS (TTM)

-1.9362

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.24

Industry PE ratio

-3.10

PEG Ratio

-0.01

EBITDA

-5.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-98.77%

Kairos Pharma, Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kairos Pharma, Ltd. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.7MNA-0.240.00%0.00%
Neutral$101.5B11.08%-35.4828.00%0.00%
StrongBuy$46.5BNA68.2588.39%0.00%
StrongBuy$138.7B194.77%34.9985.57%0.00%
Buy$93.5B46.19%19.5185.77%0.41%

Stock Returns calculator for Kairos Pharma, Ltd. Stock including INR - Dollar returns

The Kairos Pharma, Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Kairos Pharma, Ltd. investment value today

Current value as on today

₹8,639

Returns

-₹91,361

(-91.36%)

Returns from Kairos Pharma, Ltd. Stock

-₹91,841 (-91.84%)

Dollar Impact

₹481 (+0.48%)

Analyst Recommendation on Kairos Pharma, Ltd. Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Kairos Pharma, Ltd.. Average target price of $12

Kairos Pharma, Ltd. Share Price Target

Get share price movements and forecasts by analysts on Kairos Pharma, Ltd..

Current Price

$0.5

Analyzed by

1 Analysts

High

$12

0

Low

$12

Kairos Pharma, Ltd. target price $0, a slight upside of 0% compared to current price of $0.5. According to 1 analysts rating.

Indian Investors' Interest in Kairos Pharma, Ltd. Stock

Search interest for Kairos Pharma, Ltd. Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-7% versus previous 30 day period

Kairos Pharma, Ltd. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
-
0
0
-
Operating Income
0
0
0
-1
-1
-1
-1
-1
-1
-1
EBITDA
0
0
0
0
-1
-1
-1
-1
-1
-1
Interest Expense
0
0
0
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
-1
0
-1
-1
-1
-1
-1
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
0
-1
0
-1
-1
-1
-1
-1
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Kairos Pharma, Ltd. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
-
Operating Income
-1
-1
0
-1
-2
-5
EBITDA
-1
-1
0
-1
-1
-5
Interest Expense
0
0
0
0
0
-
Depreciation
-
0
0
0
0
0
Income Before Tax
-1
-2
-1
-1
-2
-5
Income Tax Expense
-
-
-
-
-
-
Net Income
-1
-2
-1
-1
-2
-5
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Kairos Pharma, Ltd. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
-1
0
-1
-1
-1
-1
-1
-1
Operating Cash Flow
0
0
-2
-1
0
0
0
-1
-1
-1
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
5
0
3
0
3
-
0
0
Change in Cash
0
0
3
-1
2
0
2
-1
0
-1

Kairos Pharma, Ltd. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-2
-1
-1
-2
-5
Operating Cash Flow
0
0
0
0
-3
-3
Investing Cash Flow
-
0
-
-
-
-
Financing Cash Flow
0
0
0
0
5
6
Change in Cash
0
0
0
0
1
3

Global Institutional Holdings in Kairos Pharma, Ltd.

Check out the Institutions with significant holdings in Kairos Pharma, Ltd..

Funds
Holdings
Neil Bhowmick
38.75%
Murali Ramachandran
8.85%
Doug Samuelson
8.66%
Hyun W. Bae
2.17%
Rahul Singhvi
1.45%

Insights on Kairos Pharma, Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 849.8% return, outperforming this stock by 942.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, KAPA stock has moved down by -41.5%

About Kairos Pharma, Ltd.

Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of antibodies and small molecules engineered to combat various malignancies, such as prostate, lung, and breast cancer, as well as glioblastoma. Initially incorporated in 2013 under the name NanoGB13, Inc., the enterprise officially adopted its current identity as Kairos Pharma, Ltd. in July 2016. The company's operations are headquartered in Los Angeles, California.
OrganisationKairos Pharma, Ltd.
Headquarters2355 Westwood Blvd., Los Angeles, CA, 90064, US
IndustryBiotechnology
CEOJohn S. Yu

Key Management of Kairos Pharma, Ltd.

Name

Title

Mr. Douglas W. Samuelson CPA

Chief Financial Officer

Dr. Neil A. Bhowmick Ph.D.

Chief Scientific Officer

Dr. Ramachandran Murali Ph.D.

Vice President of Research & Development

Dr. John S. Yu M.D., Ph.D.

CEO, Chairman & Secretary

FAQs

What is Kairos Pharma, Ltd. share price today?

Kairos Pharma, Ltd. share price today is $0.50 as on . Kairos Pharma, Ltd. share today touched a day high of $0.51 and a low of $0.47.

What is the 52 week high and 52 week low for Kairos Pharma, Ltd. share?

Kairos Pharma, Ltd. share touched a 52 week high of $7.28 on and a 52 week low of $0.42 on . Kairos Pharma, Ltd. stock price today i.e. is trending at $0.50,which is 93.13% down from its 52 week high and 19.56% up from its 52 week low.

What is Kairos Pharma, Ltd.'s market capitalisation today?

Kairos Pharma, Ltd. market capitalisation is $0.00T as on .

How to invest in Kairos Pharma, Ltd. Stock (KAPA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kairos Pharma, Ltd. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Kairos Pharma, Ltd. Stock (KAPA) from India?

Indian investors can start investing in Kairos Pharma, Ltd. (KAPA) shares with as little as ₹93.68000030517578 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.80 in Kairos Pharma, Ltd. stock (as per the Rupee-Dollar exchange rate as on ). Based on Kairos Pharma, Ltd. share’s latest price of $0.50 as on November 12, 2026 at 2:24 am IST, you will get 20.0000 shares of Kairos Pharma, Ltd.. Learn more about fractional shares .